YmAbs Therapeutics (YMAB)
(Real Time Quote from BATS)
$11.79 USD
-0.40 (-3.28%)
Updated May 14, 2024 03:59 PM ET
After-Market: $11.80 +0.01 (0.08%) 4:14 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.10 | 3.22% |
Earnings Summary
For their last quarter, YmAbs Therapeutics (YMAB) reported earnings of -$0.15 per share, missing the Zacks Consensus Estimate of -$0.12 per share. This reflects a negative earnings surprise of 25.00%. Look out for YMAB's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.10 per share, reflecting a year-over-year increase of 28.57%.
Earnings History
Price & Consensus
Zacks News for YMAB
New Strong Buy Stocks for April 19th
YMAB: What are Zacks experts saying now?
Zacks Private Portfolio Services